Angelman Syndrome Treatment Market Size, Product Launch, Major Companies, Revenue Analysis Till 2030
Angelman Syndrome (AS) is a rare neurodevelopmental disorder caused by a genetic abnormality affecting the maternal copy of the UBE3A gene on chromosome 15. It affects approximately 1 in 15,000 individuals worldwide. AS is characterized by developmental delays, intellectual disabilities, speech impairments, motor difficulties, and a unique behavioral profile, including a happy demeanor,...
0 Comments 0 Shares 977 Views 0 Reviews